Showing results 1 to 50 from more than 300,000 results:

Dyskinesia: Top KOLs in the world



World Rank Name Topic PersonRank Score help
#1
Jonathan ******* ******** (Reveal full name)
Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. | Toronto Western Hospital, University Health Network, Krembil Neuroscience Centre, Toronto, Canada | Toronto Western Hospital, University Health Ne
DyskinesiaReveal score
#2
Susan * *** (Reveal full name)
Edmond J. Safra Program in Parkinson's Disease, Rossy Progressive Supranuclear Palsy Centre, Movement Disorders Clinic, Krembil Brain Institute, Toronto Western Hospital, University Health Network and Division of Neurology, University of Toronto, Tor
DyskinesiaReveal score
#3
Maria ****** ***** (Reveal full name)
Basal Ganglia Pathophysiology Unit, Dept. Experimental Medical Science, Lund University, Sweden. Electronic address: Angela.Cenci_Nilsson@med.lu.se. | Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, 22
DyskinesiaReveal score
#4
Erwan ****** (Reveal full name)
Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France | University of Bordeaux: Universite de Bordeaux | Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France |
DyskinesiaReveal score
#5
Alan * ******** (Reveal full name)
University of Manchester, Manchester M13 9PL, UK. | Motac Neuroscience, Manchester, M15 6WE, United Kingdom | University of Manchester, Manchester, UK | Faculty of Life Sciences, University of Manchester, Manchester M13 9PL, UK | Faculty of Life Scie
DyskinesiaReveal score
#6
Thére`se ** ***** (Reveal full name)
Faculté de pharmacie, Pavillon Ferdinand-Vandry, 1050, avenue de la Médecine, Université Laval, Québec (Québec) G1V 0A6, Canada | Neuroscience Research Unit, CHU de Québec Research Centre and the Faculty of Pharmacy, Laval University, Québec City, Qu
DyskinesiaReveal score
#7
Joseph * ******** (Reveal full name)
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA | Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Housto
DyskinesiaReveal score
#8
José ***** ***** (Reveal full name)
Universidad San Pablo-CEU, Madrid, Spain. | CIBERNED, Instituto de Salud Carlos III, Madrid, Spain. | HM CINAC (Centro Integral de Neurociencias Abarca Campal), Fundación Hospitales de Madrid, Hospital Universitario HM Puerta del Sur, HM Hospitales,
DyskinesiaReveal score
#9
Christopher * ***** (Reveal full name)
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA. | Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States. | Rush University Medical Center, Chicago, Illinois, USA | Rush
DyskinesiaReveal score
#10
Olivier ****** (Reveal full name)
Toulouse Parkinson Expert Center, Departments of Neurosciences and Clinical Pharmacology, Centre d’Investigation Clinique de Toulouse CIC1436, NS-Park/FCRIN Network, and NeuroToul COEN Center, University Hospital of Toulouse, INSERM, University of To
DyskinesiaReveal score
#11
Thomas * ***** (Reveal full name)
KM Pharmaceutical Consulting LLC, Washington, DC 20006, USA;, tchase@chasetherapeutics.com, (T.N.C.);, mkoga@kmphc.com, (M.K.) | KM Pharmaceutical Consulting LLC, Washington, District of Columbia | Chase Pharmaceuticals, Inc, 1825 K Street NW, Washin
DyskinesiaReveal score
#12
Charles * ****** (Reveal full name)
Clintrex Research Corp, Sarasota, FL, USA | Mount Sinai School of Medicine, New York, NY, USA; Clintrex, Research Corporation, Sarasota, FL, USA. Electronic address: warren.olanow@clintrex.com. | Clintrex Research Corporation, Sarasota, Florida, USA
DyskinesiaReveal score
#13
Stanley **** (Reveal full name)
Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA | Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA | H. Houston Merritt Professor Emeritus of
DyskinesiaReveal score
#14
Anthony ****** **** (Reveal full name)
Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital and Division of Neurology, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada | Department of Me
DyskinesiaReveal score
#15
Andrew **** ****** (Reveal full name)
Reta Lila Weston Institute, Institute of Neurology, UCL and National Hospital, Queen Square, London, United Kingdom | Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, London, UK | University Colle
DyskinesiaReveal score
#16
Werner * ***** (Reveal full name)
Department of Neurology, Innsbruck Medical University, 6020 Innsbruck, Austria | Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria | Department of Neurology, Innsbruck Medical University, Innsbruck, Austria | Department of
DyskinesiaReveal score
#17
C ***** ******* (Reveal full name)
MRC Movement Disorders Research Group, University Department of Neurology and Parkinson's Disease Society Research Centre, Institute of Psychiatry and King's College Hospital Medical School, Denmark Hill, London SE5 8AF, UK | M.R.C. Movement Disorder
DyskinesiaReveal score
#18
For *** ****** ******* ********** **** *** ******* (Reveal full name)

DyskinesiaReveal score
#19
From ***** ********* ** *** *** ******* **** **** (Reveal full name)

DyskinesiaReveal score


Extent Of Pre-Operative L-Dopa-Induced Dyskinesia Predicts The Severity Of...

.. Graft-induced dyskinesia has emerged as a problematic side effect after transplantation of fetal dopamine cells into the striatum of patients with Parkinson's disease. These adverse ...

Also Ranks for: Induced Dyskinesia |  parkinsons disease |  development graft |  cell transplantation |  rat model

Unilateral Pallidotomy In 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated...

.. levodopa-induced dyskinesia without worsening motor symptoms. The reasons for this are not clear and no experimental study has investigated this phenomenon. The objective of this ...

Also Ranks for: Induced Dyskinesia |  common marmosets |  motor disability |  globus pallidus |  levodopa primed

Gdnf Reverses Priming For Dyskinesia In Mptp‐treated, L‐dopa‐primed Common Marmosets

.. of dyskinesia. In rodent and primate studies, glial cell line-derived neurotrophic factor (GDNF) may prevent 6-OHDA- or MPTP-induced nigral degeneration and so may be beneficial in the ...

Also Ranks for: Substantia Nigra |  locomotor activity |  treated animals |  caudate nucleus |  induced dyskinesia